Bavarian Nordic A/S (OTCMKTS:BVNRY - Get Free Report) shares reached a new 52-week low during trading on Monday . The stock traded as low as $6.60 and last traded at $6.84, with a volume of 10147 shares traded. The stock had previously closed at $6.90.
Bavarian Nordic A/S Price Performance
The firm has a 50 day moving average price of $7.75 and a 200-day moving average price of $8.95. The firm has a market capitalization of $1.77 billion, a price-to-earnings ratio of 10.84 and a beta of 1.55.
Bavarian Nordic A/S (OTCMKTS:BVNRY - Get Free Report) last posted its earnings results on Wednesday, March 5th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.07. The firm had revenue of $299.48 million during the quarter, compared to analysts' expectations of $264.06 million. Bavarian Nordic A/S had a return on equity of 10.65% and a net margin of 18.33%. Equities research analysts predict that Bavarian Nordic A/S will post 0.67 earnings per share for the current year.
About Bavarian Nordic A/S
(
Get Free Report)
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
Featured Stories
Before you consider Bavarian Nordic A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bavarian Nordic A/S wasn't on the list.
While Bavarian Nordic A/S currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
